Péter Tátrai Selected Research

Agrin

1/2016	Proteoglycans in liver cancer.
9/2010	Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
6/2009	Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
12/2008	[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
10/2007	Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
11/2006	Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
1/2004	[Proteoglycans in the liver].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Péter Tátrai Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 05/2006
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2004
6	Liver Neoplasms (Liver Cancer) 03/2021 - 01/2004
6	Carcinoma (Carcinomatosis) 01/2020 - 05/2006
5	Carcinogenesis 01/2022 - 05/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2004
4	Fibrosis (Cirrhosis) 03/2021 - 11/2006
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 09/2010
2	Liver Diseases (Liver Disease) 01/2022 - 05/2010
2	Pathologic Processes 01/2022 - 05/2010
2	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2010
2	Synovial Sarcoma (Synovioma) 10/2017 - 10/2012
2	Cholangiocarcinoma 09/2010 - 10/2007
2	Adenoma (Adenomas) 03/2010 - 12/2008
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2009 - 02/2009
1	Hepatitis C 01/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Macrocytic Anemia 01/2022
1	Gout 06/2021
1	Non-alcoholic Fatty Liver Disease 03/2021
1	Hyperbilirubinemia 08/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Rhabdomyosarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Dwarfism 03/2016
1	Microcephaly 03/2016
1	Infections 07/2014
1	Adenocarcinoma 09/2010
1	Pancreatic Ductal Carcinoma 09/2010
1	Follicular Adenocarcinoma 03/2010
1	Lymphatic Metastasis 03/2010
1	Papillary Thyroid Cancer 03/2010
1	Focal Nodular Hyperplasia 06/2009
1	Leiomyoma (Uterine Fibroids) 05/2006
1	Squamous Cell Carcinoma of Head and Neck 05/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2006

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2021 - 05/2006
7	AgrinIBA 01/2016 - 01/2004
5	Syndecan-1 (Syndecan 1)IBA 01/2022 - 01/2004
4	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 01/2004
3	Proteoglycans (Proteoglycan)IBA 01/2020 - 01/2004
3	DecorinIBA 01/2020 - 01/2020
3	ClaudinsIBA 07/2014 - 02/2009
3	Claudin-1IBA 07/2014 - 02/2009
3	Messenger RNA (mRNA)IBA 03/2010 - 10/2007
2	CateninsIBA 03/2021 - 10/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
2	Small Leucine-Rich ProteoglycansIBA 01/2020 - 01/2020
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2020
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 09/2010 - 10/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2010 - 11/2006
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 03/2006
1	Chondroitin Sulfate ProteoglycansIBA 01/2022
1	Uric Acid (Urate)IBA 06/2021
1	AntioxidantsIBA 06/2021
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2021
1	BilirubinIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	XenobioticsIBA 08/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Keratins (Keratin)IBA 10/2017
1	Cyclin D1IBA 10/2017
1	Versicans (Versican)IBA 01/2016
1	GlypicansIBA 01/2016
1	Matrilin ProteinsIBA 01/2014
1	Lysine (L-Lysine)FDA Link 10/2012
1	Histone MethyltransferasesIBA 10/2012
1	Histones (Histone)IBA 10/2012
1	Codon (Codons)IBA 06/2011
1	Bevacizumab (Avastin)FDA Link 06/2011
1	DisaccharidesIBA 05/2010
1	AntibodiesIBA 05/2010
1	RacivirIBA 03/2010
1	beta CateninIBA 03/2010
1	OccludinIBA 09/2009
1	Cadherins (E-Cadherin)IBA 09/2009
1	Formaldehyde (Formol)FDA Link 06/2009
1	ParaffinIBA 06/2009
1	Claudin-4IBA 02/2009
1	claudin 10IBA 02/2009
1	IntegrinsIBA 11/2006
1	Biological ProductsIBA 01/2004

Therapy/Procedure

3	Therapeutics 01/2018 - 06/2011
1	Drug Therapy (Chemotherapy) 01/2022